BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51447 Oc1c(nc(N2CCCC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H16FN5O3/c22-13-7-5-12(6-8-13)11-15-25-26-21(30-15)18-19(29)17-14(3-1-9-23-17)20(24-18)27-10-2-4-16(27)28/h1,3,5-9,29H,2,4,10-11H2 KYLADZIJBXSIDN-UHFFFAOYSA-N 28240 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)pyrrolidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 7 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 19 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28240&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263131 58097429 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51448 Oc1c(nc(N2CCCCC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H18FN5O3/c23-14-8-6-13(7-9-14)12-16-26-27-22(31-16)19-20(30)18-15(4-3-10-24-18)21(25-19)28-11-2-1-5-17(28)29/h3-4,6-10,30H,1-2,5,11-12H2 MDEMTDLEXDETKM-UHFFFAOYSA-N 28241 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)piperidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 8 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 88 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28241&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263132 58097430 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51449 Oc1c(nc(N2CCCCCC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C23H20FN5O3/c24-15-9-7-14(8-10-15)13-17-27-28-23(32-17)20-21(31)19-16(5-4-11-25-19)22(26-20)29-12-3-1-2-6-18(29)30/h4-5,7-11,31H,1-3,6,12-13H2 KPMPPXUKYTVSCG-UHFFFAOYSA-N 28242 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)azepan-2-one::1,3,4-oxadiazole substituted naphthyridine, 9 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 25 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28242&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263133 58097431 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51450 CC(=O)Nc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C19H14FN5O3/c1-10(26)22-18-13-3-2-8-21-15(13)17(27)16(23-18)19-25-24-14(28-19)9-11-4-6-12(20)7-5-11/h2-8,27H,9H2,1H3,(H,22,23,26) DUSBQSDUHNZADU-UHFFFAOYSA-N 28243 N-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)acetamide::1,3,4-oxadiazole substituted naphthyridine, 10 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 72 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28243&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263134 58097432 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51451 CN(C(C)=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C20H16FN5O3/c1-11(27)26(2)19-14-4-3-9-22-16(14)18(28)17(23-19)20-25-24-15(29-20)10-12-5-7-13(21)8-6-12/h3-9,28H,10H2,1-2H3 VNAAONNUVDYKKE-UHFFFAOYSA-N 28244 N-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-methylacetamide::1,3,4-oxadiazole substituted naphthyridine, 11 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 28 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28244&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263135 58097433 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51452 CCOC(=O)C(=O)Nc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H16FN5O5/c1-2-31-21(30)19(29)25-18-13-4-3-9-23-15(13)17(28)16(24-18)20-27-26-14(32-20)10-11-5-7-12(22)8-6-11/h3-9,28H,2,10H2,1H3,(H,24,25,29) XCPLJZPKKYYYBZ-UHFFFAOYSA-N 28245 ethyl 0-[(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)carbamoyl]formate::1,3,4-oxadiazole substituted naphthyridine, 12 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 33 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28245&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263136 58097434 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51453 CN(C)C(=O)C(=O)N(C)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C22H19FN6O4/c1-28(2)21(31)22(32)29(3)19-14-5-4-10-24-16(14)18(30)17(25-19)20-27-26-15(33-20)11-12-6-8-13(23)9-7-12/h4-10,30H,11H2,1-3H3 CRCIOZGONWLDOR-UHFFFAOYSA-N 28246 N-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N',N',N''-trimethylethanediamide::1,3,4-oxadiazole substituted naphthyridine, 13 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 85 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28246&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263137 58097435 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51454 Oc1c(nc(N2CCNCC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H17FN6O3/c22-13-5-3-12(4-6-13)10-15-26-27-21(31-15)18-19(30)17-14(2-1-7-24-17)20(25-18)28-9-8-23-11-16(28)29/h1-7,23,30H,8-11H2 XEFIDAFGQLWWHR-UHFFFAOYSA-N 28247 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)piperazin-2-one::1,3,4-oxadiazole substituted naphthyridine, 14 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 38 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28247&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11270100 58097436 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51455 CN(C)C(=O)N1CCN(C(=O)C1)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H22FN7O4/c1-30(2)24(35)31-10-11-32(18(33)13-31)22-16-4-3-9-26-19(16)21(34)20(27-22)23-29-28-17(36-23)12-14-5-7-15(25)8-6-14/h3-9,34H,10-13H2,1-2H3 SZDOFGXOMUUDOV-UHFFFAOYSA-N 28248 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N,N-dimethyl-3-oxopiperazine-1-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 15 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 23 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28248&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11785162 58097437 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51456 CN1CCN(C1=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H17FN6O3/c1-27-9-10-28(21(27)30)19-14-3-2-8-23-16(14)18(29)17(24-19)20-26-25-15(31-20)11-12-4-6-13(22)7-5-12/h2-8,29H,9-11H2,1H3 CYVHFETYRROQFP-UHFFFAOYSA-N 28249 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-3-methylimidazolidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 16 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 15 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28249&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263138 58097438 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51457 Oc1c(nc(N2CCNC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C20H15FN6O3/c21-12-5-3-11(4-6-12)10-14-25-26-19(30-14)16-17(28)15-13(2-1-7-22-15)18(24-16)27-9-8-23-20(27)29/h1-7,28H,8-10H2,(H,23,29) HWGRAWFUVWOWJE-UHFFFAOYSA-N 28250 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)imidazolidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 17 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 12 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28250&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263139 58097439 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51458 OCCN1CCN(C1=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C22H19FN6O4/c23-14-5-3-13(4-6-14)12-16-26-27-21(33-16)18-19(31)17-15(2-1-7-24-17)20(25-18)29-9-8-28(10-11-30)22(29)32/h1-7,30-31H,8-12H2 QGIXPWKDWHKDMJ-UHFFFAOYSA-N 28251 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-3-(2-hydroxyethyl)imidazolidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 18 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 13 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28251&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263140 58097440 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51459 Oc1c(nc(N2CCOC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C20H14FN5O4/c21-12-5-3-11(4-6-12)10-14-24-25-19(30-14)16-17(27)15-13(2-1-7-22-15)18(23-16)26-8-9-29-20(26)28/h1-7,27H,8-10H2 LPCYUCIPAFTTQY-UHFFFAOYSA-N 28252 3-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-1,3-oxazolidin-2-one::1,3,4-oxadiazole substituted naphthyridine, 19 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 13 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28252&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11235180 58097441 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51460 Oc1c(nc(N2CCCNC2=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H17FN6O3/c22-13-6-4-12(5-7-13)11-15-26-27-20(31-15)17-18(29)16-14(3-1-8-23-16)19(25-17)28-10-2-9-24-21(28)30/h1,3-8,29H,2,9-11H2,(H,24,30) NQWXLEOIWKLFOX-UHFFFAOYSA-N 28253 1-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-1,3-diazinan-2-one::1,3,4-oxadiazole substituted naphthyridine, 20 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 11 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28253&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11316104 58097442 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51461 Oc1c(nc(N2CCCS2(=O)=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C20H16FN5O4S/c21-13-6-4-12(5-7-13)11-15-24-25-20(30-15)17-18(27)16-14(3-1-8-22-16)19(23-17)26-9-2-10-31(26,28)29/h1,3-8,27H,2,9-11H2 DEKYASBIXCFHDO-UHFFFAOYSA-N 28254 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-1,2-thiazolidine-1,1-dione::1,3,4-oxadiazole substituted naphthyridine, 21 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 8 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28254&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263141 58097443 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51462 CS(=O)(=O)Nc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C18H14FN5O4S/c1-29(26,27)24-17-12-3-2-8-20-14(12)16(25)15(21-17)18-23-22-13(28-18)9-10-4-6-11(19)7-5-10/h2-8,25H,9H2,1H3,(H,21,24) DRWKHADCISJDTN-UHFFFAOYSA-N 28255 N-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)methanesulfonamide::1,3,4-oxadiazole substituted naphthyridine, 22 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 19 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28255&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263142 58097444 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51463 CN(C)S(=O)(=O)Nc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C19H17FN6O4S/c1-26(2)31(28,29)25-18-13-4-3-9-21-15(13)17(27)16(22-18)19-24-23-14(30-19)10-11-5-7-12(20)8-6-11/h3-9,27H,10H2,1-2H3,(H,22,25) KNCYPTNNPJXEKG-UHFFFAOYSA-N 28256 5-[(dimethylsulfamoyl)amino]-7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 23 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 15 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28256&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11270722 58097445 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51464 CN1CCCN(c2nc(-c3nnc(Cc4ccc(F)cc4)o3)c(O)c3ncccc23)S1(=O)=O InChI=1S/C21H19FN6O4S/c1-27-10-3-11-28(33(27,30)31)20-15-4-2-9-23-17(15)19(29)18(24-20)21-26-25-16(32-21)12-13-5-7-14(22)8-6-13/h2,4-9,29H,3,10-12H2,1H3 UBBWGDOISNLCQW-UHFFFAOYSA-N 28257 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-6-methyl-1,2,6-thiadiazinane-1,1-dione::1,3,4-oxadiazole substituted naphthyridine, 24 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 6 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28257&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263143 58097446 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51465 CN1CCN(c2nc(-c3nnc(Cc4ccc(F)cc4)o3)c(O)c3ncccc23)S1(=O)=O InChI=1S/C20H17FN6O4S/c1-26-9-10-27(32(26,29)30)19-14-3-2-8-22-16(14)18(28)17(23-19)20-25-24-15(31-20)11-12-4-6-13(21)7-5-12/h2-8,28H,9-11H2,1H3 UWICSTGPMDAVEC-UHFFFAOYSA-N 28258 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-5-methyl-1,2,5-thiadiazolidine-1,1-dione::1,3,4-oxadiazole substituted naphthyridine, 25 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28258&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263144 58097447 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51466 Cc1ccc(cc1)S(=O)(=O)Nc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H18FN5O4S/c1-14-4-10-17(11-5-14)35(32,33)30-23-18-3-2-12-26-20(18)22(31)21(27-23)24-29-28-19(34-24)13-15-6-8-16(25)9-7-15/h2-12,31H,13H2,1H3,(H,27,30) VAXKYGIMPJPKIX-UHFFFAOYSA-N 28259 N-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-4-methylbenzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 26 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 42 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28259&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263145 58097448 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51467 Oc1c(nc(N2CCNC(=O)C2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H17FN6O3/c22-13-5-3-12(4-6-13)10-16-26-27-21(31-16)18-19(30)17-14(2-1-7-24-17)20(25-18)28-9-8-23-15(29)11-28/h1-7,30H,8-11H2,(H,23,29) DPSWMKPGUBLRDC-UHFFFAOYSA-N 28260 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)piperazin-2-one::1,3,4-oxadiazole substituted naphthyridine, 27 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 7 7.2000 37.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28260&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263146 58097449 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51468 CNc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C18H14FN5O2/c1-20-17-12-3-2-8-21-14(12)16(25)15(22-17)18-24-23-13(26-18)9-10-4-6-11(19)7-5-10/h2-8,25H,9H2,1H3,(H,20,22) QZQSJZJJAOMHNA-UHFFFAOYSA-N 28261 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(methylamino)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 29 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 74 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28261&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263147 58097450 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51469 CS(=O)(=O)N1CCN(CC1)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C22H21FN6O4S/c1-34(31,32)29-11-9-28(10-12-29)21-16-3-2-8-24-18(16)20(30)19(25-21)22-27-26-17(33-22)13-14-4-6-15(23)7-5-14/h2-8,30H,9-13H2,1H3 BAXCOWGDESVVNU-UHFFFAOYSA-N 28262 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(4-methanesulfonylpiperazin-1-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 30 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 19 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28262&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263148 58097451 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51470 CN(C)C(=O)CN1CCN(CC1)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H26FN7O3/c1-31(2)20(34)15-32-10-12-33(13-11-32)24-18-4-3-9-27-21(18)23(35)22(28-24)25-30-29-19(36-25)14-16-5-7-17(26)8-6-16/h3-9,35H,10-15H2,1-2H3 OIPIGLANOZDFIQ-UHFFFAOYSA-N 28263 2-[4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)piperazin-1-yl]-N,N-dimethylacetamide::1,3,4-oxadiazole substituted naphthyridine, 31 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 12 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28263&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263149 58097452 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51471 Oc1c(nc(-c2ccccc2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C23H15FN4O2/c24-16-10-8-14(9-11-16)13-18-27-28-23(30-18)21-22(29)20-17(7-4-12-25-20)19(26-21)15-5-2-1-3-6-15/h1-12,29H,13H2 WAVJGSJSVSZKKY-UHFFFAOYSA-N 28264 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-phenyl-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 32 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 29 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28264&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263150 58097453 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51472 Oc1c(nc(-c2ccccn2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H14FN5O2/c23-14-8-6-13(7-9-14)12-17-27-28-22(30-17)20-21(29)19-15(4-3-11-25-19)18(26-20)16-5-1-2-10-24-16/h1-11,29H,12H2 KSPLGMFQGYKOBY-UHFFFAOYSA-N 28265 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(pyridin-2-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 33 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 30 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28265&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11463700 58097454 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51473 Oc1c(nc(-c2cccnc2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H14FN5O2/c23-15-7-5-13(6-8-15)11-17-27-28-22(30-17)20-21(29)19-16(4-2-10-25-19)18(26-20)14-3-1-9-24-12-14/h1-10,12,29H,11H2 XGFVMXZAPHWFJT-UHFFFAOYSA-N 28266 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(pyridin-3-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 34 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 11 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28266&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263151 58097455 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51474 Oc1c(nc(-c2ccncc2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H14FN5O2/c23-15-5-3-13(4-6-15)12-17-27-28-22(30-17)20-21(29)19-16(2-1-9-25-19)18(26-20)14-7-10-24-11-8-14/h1-11,29H,12H2 IUMHLAGWWNQZDQ-UHFFFAOYSA-N 28267 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(pyridin-4-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 35 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 8 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28267&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263152 58097456 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51475 Oc1c(nc(-c2cnccn2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H13FN6O2/c22-13-5-3-12(4-6-13)10-16-27-28-21(30-16)19-20(29)18-14(2-1-7-25-18)17(26-19)15-11-23-8-9-24-15/h1-9,11,29H,10H2 HRHATTAFJPWMSS-UHFFFAOYSA-N 28268 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(pyrazin-2-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 36 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 20 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28268&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11452348 58097457 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51476 OC(=O)c1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H15FN4O4/c25-16-8-6-13(7-9-16)11-18-28-29-23(33-18)21-22(30)20-17(5-2-10-26-20)19(27-21)14-3-1-4-15(12-14)24(31)32/h1-10,12,30H,11H2,(H,31,32) OYJPDIBLEVFXFO-UHFFFAOYSA-N 28269 3-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)benzoic acid::1,3,4-oxadiazole substituted naphthyridine, 37 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 2 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28269&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25256802 58097458 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51477 CC(C)NC(=O)c1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C27H22FN5O3/c1-15(2)30-26(35)18-6-3-5-17(14-18)22-20-7-4-12-29-23(20)25(34)24(31-22)27-33-32-21(36-27)13-16-8-10-19(28)11-9-16/h3-12,14-15,34H,13H2,1-2H3,(H,30,35) YOGFIUUAUFTAKN-UHFFFAOYSA-N 28270 3-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-(propan-2-yl)benzamide::1,3,4-oxadiazole substituted naphthyridine, 38 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 10 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28270&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263153 58097459 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51478 Nc1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C23H16FN5O2/c24-15-8-6-13(7-9-15)11-18-28-29-23(31-18)21-22(30)20-17(5-2-10-26-20)19(27-21)14-3-1-4-16(25)12-14/h1-10,12,30H,11,25H2 ZHAZFRYZSCGESN-UHFFFAOYSA-N 28271 5-(3-aminophenyl)-7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 39 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 15 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28271&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263154 58097460 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51479 CC(=O)Nc1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H18FN5O3/c1-14(32)28-18-5-2-4-16(13-18)21-19-6-3-11-27-22(19)24(33)23(29-21)25-31-30-20(34-25)12-15-7-9-17(26)10-8-15/h2-11,13,33H,12H2,1H3,(H,28,32) YNELRVUKEUDBSB-UHFFFAOYSA-N 28272 N-[3-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)phenyl]acetamide::1,3,4-oxadiazole substituted naphthyridine, 40 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 80 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28272&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263155 58097461 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51480 CS(=O)(=O)Nc1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H18FN5O4S/c1-35(32,33)30-17-5-2-4-15(13-17)20-18-6-3-11-26-21(18)23(31)22(27-20)24-29-28-19(34-24)12-14-7-9-16(25)10-8-14/h2-11,13,30-31H,12H2,1H3 DWSOCBIUCWMILK-UHFFFAOYSA-N 28273 N-[3-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)phenyl]methanesulfonamide::1,3,4-oxadiazole substituted naphthyridine, 41 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 8 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28273&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11420462 58097462 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51481 OC(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H15FN4O4/c25-16-9-3-13(4-10-16)12-18-28-29-23(33-18)21-22(30)20-17(2-1-11-26-20)19(27-21)14-5-7-15(8-6-14)24(31)32/h1-11,30H,12H2,(H,31,32) OAGRTSABNXXFBS-UHFFFAOYSA-N 28274 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)benzoic acid::1,3,4-oxadiazole substituted naphthyridine, 42 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 2 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28274&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11453518 58097463 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51482 NC(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H16FN5O3/c25-16-9-3-13(4-10-16)12-18-29-30-24(33-18)21-22(31)20-17(2-1-11-27-20)19(28-21)14-5-7-15(8-6-14)23(26)32/h1-11,31H,12H2,(H2,26,32) XYWTYUUYUQJEKQ-UHFFFAOYSA-N 28275 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)benzamide::1,3,4-oxadiazole substituted naphthyridine, 43 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 6 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28275&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263156 58097464 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51483 CNC(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H18FN5O3/c1-27-24(33)16-8-6-15(7-9-16)20-18-3-2-12-28-21(18)23(32)22(29-20)25-31-30-19(34-25)13-14-4-10-17(26)11-5-14/h2-12,32H,13H2,1H3,(H,27,33) CWJJPIXJMBATKQ-UHFFFAOYSA-N 28276 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-methylbenzamide::1,3,4-oxadiazole substituted naphthyridine, 44 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28276&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263157 58097465 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51484 CN(C)C(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C26H20FN5O3/c1-32(2)26(34)17-9-7-16(8-10-17)21-19-4-3-13-28-22(19)24(33)23(29-21)25-31-30-20(35-25)14-15-5-11-18(27)12-6-15/h3-13,33H,14H2,1-2H3 DBRYFDBKGOJQHJ-UHFFFAOYSA-N 28277 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N,N-dimethylbenzamide::1,3,4-oxadiazole substituted naphthyridine, 45 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 18 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28277&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11431323 58097466 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51485 CC(C)NC(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C27H22FN5O3/c1-15(2)30-26(35)18-9-7-17(8-10-18)22-20-4-3-13-29-23(20)25(34)24(31-22)27-33-32-21(36-27)14-16-5-11-19(28)12-6-16/h3-13,15,34H,14H2,1-2H3,(H,30,35) UVMMYYFIVCXCTA-UHFFFAOYSA-N 28278 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-(propan-2-yl)benzamide::1,3,4-oxadiazole substituted naphthyridine, 46 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28278&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11225444 58097467 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51486 CN(C)S(=O)(=O)c1ccccc1-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H20FN5O4S/c1-31(2)36(33,34)19-8-4-3-6-17(19)21-18-7-5-13-27-22(18)24(32)23(28-21)25-30-29-20(35-25)14-15-9-11-16(26)12-10-15/h3-13,32H,14H2,1-2H3 YPTDIWSESNLMTB-UHFFFAOYSA-N 28279 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N,N-dimethylbenzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 47 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28279&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263158 58097468 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51487 CN(C)S(=O)(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H20FN5O4S/c1-31(2)36(33,34)18-11-7-16(8-12-18)21-19-4-3-13-27-22(19)24(32)23(28-21)25-30-29-20(35-25)14-15-5-9-17(26)10-6-15/h3-13,32H,14H2,1-2H3 NXCMMNZJDXSXPD-UHFFFAOYSA-N 28280 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N,N-dimethylbenzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 48 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 18 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28280&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263159 58097469 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51488 CNS(=O)(=O)c1ccccc1-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H18FN5O4S/c1-26-35(32,33)18-7-3-2-5-16(18)20-17-6-4-12-27-21(17)23(31)22(28-20)24-30-29-19(34-24)13-14-8-10-15(25)11-9-14/h2-12,26,31H,13H2,1H3 GGIXDBQCHGYSDF-UHFFFAOYSA-N 28281 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-methylbenzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 49 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28281&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263160 58097470 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51489 CC(C)NS(=O)(=O)c1ccccc1-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C26H22FN5O4S/c1-15(2)32-37(34,35)20-8-4-3-6-18(20)22-19-7-5-13-28-23(19)25(33)24(29-22)26-31-30-21(36-26)14-16-9-11-17(27)12-10-16/h3-13,15,32-33H,14H2,1-2H3 KPBYAVZJPLTINC-UHFFFAOYSA-N 28282 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-(propan-2-yl)benzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 50 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 12 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28282&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263161 58097471 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51490 Oc1c(nc(N2CCCCS2(=O)=O)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H18FN5O4S/c22-14-7-5-13(6-8-14)12-16-25-26-21(31-16)18-19(28)17-15(4-3-9-23-17)20(24-18)27-10-1-2-11-32(27,29)30/h3-9,28H,1-2,10-12H2 PKDXCDDPOQGIND-UHFFFAOYSA-N 28239 2-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-1,2-thiazinane-1,1-dione::BMCL191807 Compound 2::C5-sultam substituted naphthyridine, 33 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 2 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28239&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11236396 58097428 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51491 CC(C)NS(=O)(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C26H22FN5O4S/c1-15(2)32-37(34,35)19-11-7-17(8-12-19)22-20-4-3-13-28-23(20)25(33)24(29-22)26-31-30-21(36-26)14-16-5-9-18(27)10-6-16/h3-13,15,32-33H,14H2,1-2H3 YWUITJZSFYRDLL-UHFFFAOYSA-N 28283 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)-N-(propan-2-yl)benzene-1-sulfonamide::1,3,4-oxadiazole substituted naphthyridine, 51 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28283&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263162 58097472 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51492 CC(=O)Nc1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C25H18FN5O3/c1-14(32)28-18-10-6-16(7-11-18)21-19-3-2-12-27-22(19)24(33)23(29-21)25-31-30-20(34-25)13-15-4-8-17(26)9-5-15/h2-12,33H,13H2,1H3,(H,28,32) GVCDCTSHHCUSRI-UHFFFAOYSA-N 28284 N-[4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)phenyl]acetamide::1,3,4-oxadiazole substituted naphthyridine, 52 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28284&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11166962 58097473 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51493 CS(=O)(=O)Nc1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H18FN5O4S/c1-35(32,33)30-17-10-6-15(7-11-17)20-18-3-2-12-26-21(18)23(31)22(27-20)24-29-28-19(34-24)13-14-4-8-16(25)9-5-14/h2-12,30-31H,13H2,1H3 OQKLVAKESMOGRL-UHFFFAOYSA-N 28285 N-[4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)phenyl]methanesulfonamide::1,3,4-oxadiazole substituted naphthyridine, 53 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 3 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28285&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263163 58097474 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51494 CS(=O)(=O)c1ccccc1-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H17FN4O4S/c1-34(31,32)18-7-3-2-5-16(18)20-17-6-4-12-26-21(17)23(30)22(27-20)24-29-28-19(33-24)13-14-8-10-15(25)11-9-14/h2-12,30H,13H2,1H3 FNQKXILIIVSGEJ-UHFFFAOYSA-N 28286 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(2-methanesulfonylphenyl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 54 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 11 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28286&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263164 58097475 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51495 CS(=O)(=O)c1cccc(c1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H17FN4O4S/c1-34(31,32)17-5-2-4-15(13-17)20-18-6-3-11-26-21(18)23(30)22(27-20)24-29-28-19(33-24)12-14-7-9-16(25)10-8-14/h2-11,13,30H,12H2,1H3 PGEHXNGNDFMCRL-UHFFFAOYSA-N 28287 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(3-methanesulfonylphenyl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 55 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 6 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28287&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263165 58097476 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51496 CS(=O)(=O)c1ccc(cc1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C24H17FN4O4S/c1-34(31,32)17-10-6-15(7-11-17)20-18-3-2-12-26-21(18)23(30)22(27-20)24-29-28-19(33-24)13-14-4-8-16(25)9-5-14/h2-12,30H,13H2,1H3 OCLGJFKJPFBIRS-UHFFFAOYSA-N 28288 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(4-methanesulfonylphenyl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 56 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 9 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28288&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263166 58097477 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51497 Oc1c(nc(-c2ccc(cc2)C#N)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C24H14FN5O2/c25-17-9-5-14(6-10-17)12-19-29-30-24(32-19)22-23(31)21-18(2-1-11-27-21)20(28-22)16-7-3-15(13-26)4-8-16/h1-11,31H,12H2 FFADPVCKCRZBCT-UHFFFAOYSA-N 28289 4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)benzonitrile::1,3,4-oxadiazole substituted naphthyridine, 57 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 15 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28289&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263167 58097478 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51498 Oc1c(nc(-c2ccoc2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H13FN4O3/c22-14-5-3-12(4-6-14)10-16-25-26-21(29-16)19-20(27)18-15(2-1-8-23-18)17(24-19)13-7-9-28-11-13/h1-9,11,27H,10H2 LNFQSWPCVAVJTI-UHFFFAOYSA-N 28290 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(furan-3-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 58 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 23 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28290&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 11338220 58097479 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51499 Oc1c(nc(-c2ccc[nH]2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C21H14FN5O2/c22-13-7-5-12(6-8-13)11-16-26-27-21(29-16)19-20(28)18-14(3-1-10-24-18)17(25-19)15-4-2-9-23-15/h1-10,23,28H,11H2 GBQSJWDTZOBCPL-UHFFFAOYSA-N 28291 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(1H-pyrrol-2-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 59 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 12 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28291&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263168 58097480 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51500 Oc1c(nc(-n2cccn2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C20H13FN6O2/c21-13-6-4-12(5-7-13)11-15-25-26-20(29-15)17-18(28)16-14(3-1-8-22-16)19(24-17)27-10-2-9-23-27/h1-10,28H,11H2 UJVASEBGZBXOTD-UHFFFAOYSA-N 28292 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(1H-pyrazol-1-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 60 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 4 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28292&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263169 58097481 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51501 Cc1ccn(n1)-c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H15FN6O2/c1-12-8-10-28(27-12)20-15-3-2-9-23-17(15)19(29)18(24-20)21-26-25-16(30-21)11-13-4-6-14(22)7-5-13/h2-10,29H,11H2,1H3 LOODSIUNJFYLJY-UHFFFAOYSA-N 28293 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(3-methyl-1H-pyrazol-1-yl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 61 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 21 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28293&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263170 58097482 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51502 Oc1c(nc(C#N)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C18H10FN5O2/c19-11-5-3-10(4-6-11)8-14-23-24-18(26-14)16-17(25)15-12(2-1-7-21-15)13(9-20)22-16/h1-7,25H,8H2 KFOLFCNBUUEDPU-UHFFFAOYSA-N 28294 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridine-5-carbonitrile::1,3,4-oxadiazole substituted naphthyridine, 63 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 240 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28294&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263171 58097483 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51503 NC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C18H12FN5O3/c19-10-5-3-9(4-6-10)8-12-23-24-18(27-12)15-16(25)13-11(2-1-7-21-13)14(22-15)17(20)26/h1-7,25H,8H2,(H2,20,26) LUNVMLGVSAHUMF-UHFFFAOYSA-N 28295 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 68 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 100 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28295&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263172 58097484 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51504 OC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C18H11FN4O4/c19-10-5-3-9(4-6-10)8-12-22-23-17(27-12)15-16(24)13-11(2-1-7-20-13)14(21-15)18(25)26/h1-7,24H,8H2,(H,25,26) CLHWESXETNJWNP-UHFFFAOYSA-N 28296 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridine-5-carboxylic acid::1,3,4-oxadiazole substituted naphthyridine, 69 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 860 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28296&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263173 58097485 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51505 CNC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C19H14FN5O3/c1-21-18(27)15-12-3-2-8-22-14(12)17(26)16(23-15)19-25-24-13(28-19)9-10-4-6-11(20)7-5-10/h2-8,26H,9H2,1H3,(H,21,27) JKIBMLYQURLQOD-UHFFFAOYSA-N 28297 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-N-methyl-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 70 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 120 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28297&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263174 58097486 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51506 CC(C)NC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H18FN5O3/c1-11(2)24-20(29)17-14-4-3-9-23-16(14)19(28)18(25-17)21-27-26-15(30-21)10-12-5-7-13(22)8-6-12/h3-9,11,28H,10H2,1-2H3,(H,24,29) OUUHXNLFXIWKTB-UHFFFAOYSA-N 28298 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-N-(propan-2-yl)-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 71 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 190 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28298&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263175 58097487 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51507 OCCNC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C20H16FN5O4/c21-12-5-3-11(4-6-12)10-14-25-26-20(30-14)17-18(28)15-13(2-1-7-22-15)16(24-17)19(29)23-8-9-27/h1-7,27-28H,8-10H2,(H,23,29) DYAOWSSTXXXRJK-UHFFFAOYSA-N 28299 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-N-(2-hydroxyethyl)-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 72 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 130 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28299&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263176 58097488 C04080 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51508 OCCCNC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H18FN5O4/c22-13-6-4-12(5-7-13)11-15-26-27-21(31-15)18-19(29)16-14(3-1-8-23-16)17(25-18)20(30)24-9-2-10-28/h1,3-8,28-29H,2,9-11H2,(H,24,30) JAFBQTCRHOYOJJ-UHFFFAOYSA-N 28300 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-N-(3-hydroxypropyl)-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 73 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 71 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28300&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263177 58097489 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51509 COCCNC(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C21H18FN5O4/c1-30-10-9-24-20(29)17-14-3-2-8-23-16(14)19(28)18(25-17)21-27-26-15(31-21)11-12-4-6-13(22)7-5-12/h2-8,28H,9-11H2,1H3,(H,24,29) FSBQOFVRWDUTSZ-UHFFFAOYSA-N 28301 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-N-(2-methoxyethyl)-1,6-naphthyridine-5-carboxamide::1,3,4-oxadiazole substituted naphthyridine, 74 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 190 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28301&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263178 58097490 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51510 Oc1c(nc(C(=O)N2CCOCC2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H18FN5O4/c23-14-5-3-13(4-6-14)12-16-26-27-21(32-16)19-20(29)17-15(2-1-7-24-17)18(25-19)22(30)28-8-10-31-11-9-28/h1-7,29H,8-12H2 CXKBBHHWTVXIFW-UHFFFAOYSA-N 28302 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-(morpholin-4-ylcarbonyl)-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 75 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 130 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28302&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263179 58097491 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51511 CN1CCN(CC1)C(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C23H21FN6O3/c1-29-9-11-30(12-10-29)23(32)19-16-3-2-8-25-18(16)21(31)20(26-19)22-28-27-17(33-22)13-14-4-6-15(24)7-5-14/h2-8,31H,9-13H2,1H3 DHOCHGXXFALDAS-UHFFFAOYSA-N 28303 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-[(4-methylpiperazin-1-yl)carbonyl]-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 76 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 44 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28303&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263180 58097492 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51512 OC1CCN(CC1)C(=O)c1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12 InChI=1S/C23H20FN5O4/c24-14-5-3-13(4-6-14)12-17-27-28-22(33-17)20-21(31)18-16(2-1-9-25-18)19(26-20)23(32)29-10-7-15(30)8-11-29/h1-6,9,15,30-31H,7-8,10-12H2 PZGRCTPPFRAWNF-UHFFFAOYSA-N 28304 7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-5-[(4-hydroxypiperidin-1-yl)carbonyl]-1,6-naphthyridin-8-ol::1,3,4-oxadiazole substituted naphthyridine, 77 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 27 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28304&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263181 58097493 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5 51513 Oc1c(nc(C(=O)N2CCNC(=O)C2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1 InChI=1S/C22H17FN6O4/c23-13-5-3-12(4-6-13)10-16-27-28-21(33-16)19-20(31)17-14(2-1-7-25-17)18(26-19)22(32)29-9-8-24-15(30)11-29/h1-7,31H,8-11H2,(H,24,30) HFRKFXOCBIXGHM-UHFFFAOYSA-N 28305 4-[(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)carbonyl]piperazin-2-one::1,3,4-oxadiazole substituted naphthyridine, 78 Gag-Pol polyprotein [1148-1435] Human immunodeficiency virus 1 74 Curated from the literature by BindingDB 10.1016/j.bmcl.2009.01.089 10.7270/Q2TH8K1R 19217284 aid1798877 Johns, BA; Weatherhead, JG; Allen, SH; Thompson, JB; Garvey, EP; Foster, SA; Jeffrey, JL; Miller, WH 3/15/2009 4/15/2009 Gsk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=28305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2393&target=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=28305&enzyme=Gag-Pol+polyprotein+%5B1148-1435%5D&column=ki&startPg=0&Increment=50&submit=Search 25263182 58097494 1 FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 8CBV,8CBU,8CBT,8CBS,8CBR,8BUV,8A1Q,8A1P Gag-Pol polyprotein POL_HV1H2 P04585 O09777 Q9WJC5